4th Quarter - Report

WASHINGTON STRATEGIC CONSULTING for FAMILIES OF SPINAL MUSCULAR ATROPHY

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Sought passage of the SMA Treatment Acceleration Act of 2009 (H.R. 2149 / S. 1158).

LobbyistCovered position, as disclosed
SPENCER ORAN PERLMAN —
LAUREN ELIZABETH WATTS —

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2149 (111th), S. 1158 (111th)

Budget/Appropriations BUD

Secured language in the Senate Appropriations Committee Report (S.Rept. 111-243) accompanying the FY 2011 Labor, Health & Human Services, and Education Appropriations bill (S. 3686) urging the NIH to faciliate the development of clinical trials infrastructure to support efforts to find a treatment or cure for Spinal Muscular Atrophy (SMA).

LobbyistCovered position, as disclosed
SPENCER ORAN PERLMAN —
LAUREN ELIZABETH WATTS —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Bills named: S. 3686 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.